Company news
Takara Bio Inc. news
Latest news releases, newest first. Pick a year for every news release, call and deck from that year.
Notice Regarding the Results of the Investigation into Matters of Uncertainty Concerning Accounting Treatment at Our Consolidated Subsidiary (Takara Bio USA, Inc.)
October 23, 2026
Notice of Delisting of Company Shares
June 11, 2026
Notice regarding Partial Correction of the Notice of the Extraordinary Shareholders’ Meeting
May 8, 2026
Takara Bio USA, Inc. Launches Certified Service Provider Program to Advance Research Using NGS and Single-Cell Technologies
April 16, 2026
Takara Bio USA and Hamilton Company Partner to Automate NGS Library Preparation
March 30, 2026
Takara Bio USA, Inc. Collaborates with Illumina on Spatial Transcriptomics Workflow, Details Presented at AGBT 2026
February 26, 2026
Takara Bio: Consolidated Finacial Results for the Nine Months Ended December 31, 2025
February 13, 2026
Financial Results Presentation (November 13, 2025)
November 13, 2025
Takara Bio: Consolidated Financial Results for the Six Months Ended September 30, 2025
November 11, 2025
Notice of the 23rd Annual General Meeting of Shareholders
May 28, 2025
Takara Bio launches high-throughput, cost-effective qPCR system to advance clinical research
November 20, 2024
Matters Concerning Controlling Shareholders
June 27, 2024
Notice of the 22nd Annual General Meeting of Shareholders
May 29, 2024
Annual Report 2023
September 12, 2023
Financial Results Presentation (May 16, 2023)
May 29, 2023
Notice of the 21th Annual General Meeting of Shareholders
May 22, 2023
Takara Bio: Consolidated Financial Statements for FY Ended March 31 2023
May 11, 2023
Financial Results Presentation (November 15, 2022)
November 24, 2022
Takara Bio: Consolidated Financial Statements for the Second Quarter Ended September 30, 2022
November 10, 2022
Takara Bio: Consolidated Financial Statements for the First Quarter Ended June 30, 2023
August 4, 2022
Corporate Governance Report
July 6, 2022
Takara Bio: Consolidated Financial Statements for the Third Quarter Ended December 31, 2021
February 9, 2022
Financial Results Presentation (November 11, 2021)
December 13, 2021
Annual Report 2021
November 15, 2021